Literature DB >> 9443780

Serum ionized magnesium: relation to blood pressure and racial factors.

L M Resnick1, O Bardicef, B T Altura, M H Alderman, B M Altura.   

Abstract

To study potential ionic factors predisposing to vascular disease in hypertension, particularly among black subjects, we used a recently developed combined magnesium and calcium specific, ion selective electrode apparatus to measure extracellular ionized calcium (Ca-ion), ionized magnesium (Mg-ion), and Ca-ion/Mg-ion ratios in the serum of fasting, nonmedicated white and black normotensive (n = 61) and hypertensive (n = 23) subjects, studied consecutively in a tertiary referral center. Both race and blood pressure status had independent effects on the distribution of Mg-ion values. Although Mg-ion levels for the group as a whole were lower in hypertensive versus in normotensive subjects (0.571+/-0.012 v 0.601+/-0.005 mmol/L; P < .01), this was only true of white subjects (0.579+/-0.021 v 0.620+/-0.006 mmol/L; P = .0095). The lack of a significant difference in Mg-ion levels between black hypertensive versus normotensive subjects (0.553+/-0.012 v 0.577+/-0.007 mmol/L, P = NS) was attributable to the significantly lower Mg-ion levels present in normotensive blacks compared to those in normotensive white subjects (0.577+/-0.007 v 0.620+/-0.006 mmol/L, P = .0001). Resultant Ca-ion/Mg-ion ratios were elevated in all black subjects and in white hypertensive subjects. These data support the presence among hypertensives and among black subjects (independently of blood pressure) of a consistent depletion of circulating magnesium and of an imbalance of calcium and magnesium that may potentiate vascular disease among these subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9443780     DOI: 10.1016/s0895-7061(97)00364-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

1.  Short-term magnesium deficiency downregulates telomerase, upregulates neutral sphingomyelinase and induces oxidative DNA damage in cardiovascular tissues: relevance to atherogenesis, cardiovascular diseases and aging.

Authors:  Nilank C Shah; Gatha J Shah; Zhiqiang Li; Xian-Cheng Jiang; Bella T Altura; Burton M Altura
Journal:  Int J Clin Exp Med       Date:  2014-03-15

2.  Acute decrease in serum magnesium level after ischemic stroke may not predict decrease in neurologic function.

Authors:  James E Siegler; Amelia K Boehme; Karen C Albright; Sami Bdeir; Anoop K Kar; Leann Myers; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-07-04       Impact factor: 2.136

3.  Sphingolipids regulate [Mg2+]o uptake and [Mg2+]i content in vascular smooth muscle cells: potential mechanisms and importance to membrane transport of Mg2+.

Authors:  Tao Zheng; Wenyan Li; Bella T Altura; Nilank C Shah; Burton M Altura
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

Review 4.  Magnesium deficiency in African-Americans: does it contribute to increased cardiovascular risk factors?

Authors:  Chester H Fox; Martin C Mahoney; Delano Ramsoomair; Cathleen A Carter
Journal:  J Natl Med Assoc       Date:  2003-04       Impact factor: 1.798

5.  Evaluation of serum magnesium differences in hypertensive crises and control patients: A randomly matched case-control study.

Authors:  IfeanyiChukwu O Onor; Emily K Johnston; Nicole G Little; Lashira M Hill; Oluwabunmi E Lawal; Casey J Payne; Mallory R Coleman; Carolkim H Huynh; Sarah E Bilbe; Ahlam A Ayyad; Kabrea J Jones; Jasmine D Kinnard; Rosanna Dastoori; Devinn K Rolland; Amanda S Miller; Robbie A Beyl; Christopher J Gillard; John I Okogbaa; Daniel F Sarpong; Rim M Hadgu; Amne Borghol; Samuel C Okpechi; Mihran V Naljayan; Shane E Sanne; Shane G Guillory
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-05-08       Impact factor: 3.738

6.  Genetic loci for serum magnesium among African-Americans and gene-environment interaction at MUC1 and TRPM6 in European-Americans: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Adrienne Tin; Anna Köttgen; Aaron R Folsom; Nisa M Maruthur; Salman M Tajuddin; Mike A Nalls; Michele K Evans; Alan B Zonderman; Christopher A Friedrich; Eric Boerwinkle; Josef Coresh; Wen Hong Linda Kao
Journal:  BMC Genet       Date:  2015-05-29       Impact factor: 2.797

Review 7.  Dose-response relationship between dietary magnesium intake, serum magnesium concentration and risk of hypertension: a systematic review and meta-analysis of prospective cohort studies.

Authors:  Hedong Han; Xin Fang; Xin Wei; Yuzhou Liu; Zhicao Jin; Qi Chen; Zhongjie Fan; Jan Aaseth; Ayako Hiyoshi; Jia He; Yang Cao
Journal:  Nutr J       Date:  2017-05-05       Impact factor: 3.271

8.  Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease.

Authors:  D Hendrik N van den Broek; Yu-Mei Chang; Jonathan Elliott; Rosanne E Jepson
Journal:  J Vet Intern Med       Date:  2018-04-27       Impact factor: 3.333

Review 9.  Association of hypomagnesemia with cardiovascular diseases and hypertension.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Int J Cardiol Hypertens       Date:  2019-04-23

10.  Additional antihypertensive effect of magnesium supplementation with an angiotensin II receptor blocker in hypomagnesemic rats.

Authors:  Kyubok Jin; Tae Hee Kim; Yeong Hoon Kim; Yang Wook Kim
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.